More adults with IgE-mediated peanut allergy receiving remibrutinib vs. placebo for 4 weeks tolerated a single dose of at least 600 mg peanut protein without dose-limiting symptoms, according to a ...

PHB-050 is currently in a Phase 1 clinical trial for food allergy. The ongoing trial is expected to generate key data on safety, pharmacokinetics and the potential to rapidly reduce circulating IgE ...

To inform clinicians on the best biologic agent for different populations of adults with severe asthma, 12 experts collaborated on a new clinical practice guideline published in CHEST, according to a ...

Poplar Therapeutics is seeking a “step change” in the treatment of food allergy and other atopic conditions, with $95 million ...

Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.

Parents across the U.S. are introducing peanut products to their infants earlier than ever, following guidelines that the ...

Among other highlights of a new national status report is that only 5200 allergists practice in the US, which translates to 1 ...

Exposure to more germs may backfire for adult asthma sufferers In A Nutshell A new mouse study from Cornell University found that adult mice exposed to a wide variety of microbes developed more severe ...

Beyond symptoms like burning, swelling, itching, and general irritation, it can even interfere with your ability to conceive.

Research presented at AAAAI studied the relationship between race and patient characteristics in patients with CSU. Dr Mosnaim discussed the findings.

An Australian teenager who died after eating beef sausages on a camping trip has been confirmed as the nation's first death from a tick-induced meat allergy.

Regeneron-Sanofi’s Dupixent recommended by CHMP for EU approval to treat CSU in young children with ongoing symptoms despite treatment: Tarrytown, New York Wednesday, March 4, 2 ...